POLYOMAVIRUS BK VIRURIA AND VIREMIA IN DE NOVO RENAL TRANSPLANTATION COMPARING CYCLOSPORINE AND TACROLIMUS: A MULTIVARIATE ANALYSIS FROM THE DIRECT STUDY

被引：0
|
作者：
Hirsch, H. H. [1 ]
Vincenti, F. [1 ]
Friman, S. [1 ]
Wiecek, A. [1 ]
Pescovitz, M. D. [1 ]
Jenssen, T. [1 ]
Rostaing, L. [1 ]
Scheuermann, E. H. [1 ]
Citterio, F. [1 ]
Chadban, S. [1 ]
Budde, K. [1 ]
Prestele, H. [1 ]
机构：
[1] Univ Basel, Basel, Switzerland
来源：
TRANSPLANT INTERNATIONAL | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [11] Tacrolimus-Basiliximab versus cyclosporine-basiliximab in renal transplantation "De novo": Acute rejection and complications
    Garcia, DM
    Gago, JM
    Mendiluce, A
    Gordillo, R
    Bustamente, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1694 - 1696
  • [12] Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: One-year prospective study
    Pang, Xiaoli L.
    Doucette, Karen
    LeBlanc, Barbara
    Cockfield, Sandra M.
    Preiksaitis, Jutta K.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (11) : 3568 - 3573
  • [13] EVEROLIMUS PLUS TACROLIMUS IN DE-NOVO RENAL TRANSPLANTATION RECIPIENTS: PROSPECTIVE CLINICAL STUDY
    Fernandez Rivera, Constantino
    Calvo Rodriguez, Maria
    Alonso Otero, Pablo
    Lopez Muniz, Andres
    Ferreiro Hermida, Tamara
    Alonso Hernandez, Angel
    TRANSPLANT INTERNATIONAL, 2017, 30 : 475 - 475
  • [14] Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation
    Vincenti, F
    Rostaing, L
    CONTEMPORARY CLINICAL TRIALS, 2005, 26 (01) : 17 - 24
  • [15] 2-year results of the symphony study:: Comparing standard immunosuppression against low-dose cyclosporine, tacrolimus or sirolimus associated with MMF, daclizumab and corticosteroids in de-novo renal transplantation
    Ekberg, Henrik
    Tedesco-Silva, H.
    Demirbas, A.
    Vitko, S.
    Klempnauer, J.
    Guerkan, A.
    Margreiter, R.
    Hugo, C.
    Grinyo, J.
    Frei, U.
    Vanrenterghem, Y.
    Daloze, P.
    Halloran, P.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 25 - 25
  • [16] A PROSPECTIVE CLINICAL TRIAL COMPARING TACROLIMUS-MMF TO CYCLOSPORINE-EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 2 YEARS RESULTS
    Favi, Evaldo
    Citterio, Franco
    Spagnoletti, Gionata
    Gargiulo, Antonio
    Romagnoli, Jacopo
    Castagneto, Marco
    TRANSPLANT INTERNATIONAL, 2009, 22 : 241 - 241
  • [17] Oral dosing of tacrolimus and cyclosporine microemulsion - Results from a large multicenter study in renal transplantation
    Dietl, KH
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1659 - 1660
  • [18] Recurrent and de novo renal diseases after renal transplantation in the cyclosporine era: Report from the renal allograft recurrent disease registry (RARDR).
    Hariharan, S
    Peddi, VR
    First, MR
    Savin, VJ
    Roza, AM
    Johnson, C
    Adams, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3319 - A3319
  • [19] Results of LIS2T, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in De novo liver transplantation
    Levy, G
    Villamil, F
    Samuel, D
    Sanjuan, F
    Grazi, GL
    Wu, Y
    Marotta, P
    Boillot, O
    Muehlbacher, F
    Klintmalm, G
    TRANSPLANTATION, 2004, 77 (11) : 1632 - 1638
  • [20] Real-life Bioequivalence of Tacrolimus in Patients With Living-Related Donor De Novo Renal Transplantation: An Observational Study
    Naithani, Priyanka
    Dey, Sumit
    Attri, Savita Verma
    Patil, Amol
    Patial, Ajay
    Singh, Sheetal
    Panwar, Ritika
    Sivakumar, S. P.
    Singh, Sarbpreet
    Kenwar, Deepesh Benjamin
    Pattanaik, Smita
    Sharma, Ashish
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (06) : 1715 - 1717
12345